SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001513162-20-000015
Filing Date
2020-01-14
Accepted
2020-01-14 10:47:03
Documents
1
Period of Report
2020-01-14

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 3034
  Complete submission text file 0001513162-20-000015.txt   4606
Mailing Address 3150 ALMADEN EXPRESSWAY, SUITE 250 SAN JOSE CA 95118
Business Address 3150 ALMADEN EXPRESSWAY, SUITE 250 SAN JOSE CA 95118 408-708-9808
Anixa Biosciences Inc (Issuer) CIK: 0000715446 (see all company filings)

IRS No.: 112622630 | State of Incorp.: DE | Fiscal Year End: 1031
SIC: 8071 Services-Medical Laboratories
Office of Life Sciences

Mailing Address C/O ACACIA RESEARCH CORPORATION 500 NEWPORT CENTER DRIVE, 7TH FLOOR NEWPORT BEACH CA 92660
Business Address
KUMAR AMIT (Reporting) CIK: 0001191905 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37492 | Film No.: 20525259